Study population
±
Nineteen patients were randomized at one study site in Germany. Thirteen received selnoflast and six received placebo. All patients completed the study (patient disposition is shown in Figure Flow chart of patient disposition.The mean (± standard deviation [SD]) age was higher in the selnoflast arm (38.8 [± 13.7] years) compared to the placebo arm (29.4 [± 6.3] years). There was a higher proportion of males in the placebo arm (5 [83.3%] compared to 5 [38.5%] in the selnoflast arm). On average, the weight was also higher in the placebo group. Otherwise, the baseline characteristics of the patients were similar in both arms (Table Baseline characteristics of the study population.